Skip to main content

Global Oncology Biosimilars Market Expanding at 25.0% CAGR During 2017-2025

According to Goldstein Research, global oncology biosimilars market is expected to grow at 25.0% CAGR over the forecast period 2017-2025. The factors such as growth in a number of cancer patients, a rising number of hospitals, and a large number of oncology biosimilars in the pipeline are driving the growth of the Oncology Biosimilars Market. The expansion of the market is positively impacted by expanding the R&D of biomarkers such as in Cancer treatment. The Cancer Biomarker Market is still at the nascent stage and has not yet received approval from FDA, but tremendous R&D will lead to definite results in near future. Further, oncology biosimilars have initiated the trend of ‘precision medicine’ wherein tailored treatment is provided to the individual patient. Hence, the Biosimilar Market is propelling at high growth rate, such that in 2017 European Medicines Agency (EMA) had approved 16 biosimilars. Whereas, European Commission (EC), had approved 19 biosimilars for therapeutic medicines and in total 40 biosimilars across multiple categories till March 2018.
Browse Full Report: https://www.goldsteinresearch.com/report/cancer-biosimilars-market-oncology-industry
Market Segmentation
On the basis of our in-depth analysis, Global Oncology BiosimilarsMarket can be segmented as follows:
Based on Product Type
  • Monoclonal Antibody
  • Immunomodulators
  • Others
Based on Application
  • Cancer Treatment Drugs
  • Supportive Care Drugs
Based on Distribution Channel
  • Retail Pharmacies
  • Hospital Pharmacies
  • Online Pharmacies
By Region
  • North America Oncology Biosimilars Market Analysis, 2017-2025
  • Europe Oncology Biosimilars Market Analysis, 2017-2025
  • Middle East And Africa Oncology Biosimilars Market Analysis, 2017-2025
  • Latin America Oncology Biosimilars Market Analysis, 2017-2025
  • Asia Pacific Oncology Biosimilars Market Analysis, 2017-2025 
“Global Oncology Biosimilars Market Outlook 2025” includes a comprehensive overview of the global oncology biosimilars market. On the basis of our in-depth analysis, the market can be segmented in terms of market segmentation by product type, application, distribution channel and geography.
Download Exclusive Sample Report: 
https://www.goldsteinresearch.com/request-sample/cancer-biosimilars-market-oncology-industry
The Global Oncology Biosimilars Market Report highlights the competitive outlook of major global players that includes business strategies, product portfolio, revenue distribution, financial analysis, R&D activities, and investments. The comprehensive analysis of the oncology biosimilars market report is drafted as per the clients to help them in assessing their business strategies in a competitive environment.
Key players discussed in the report are:
Amgen, BoehringerIngelheim, Novartis, Biocon, Roche and many more.
Further, Global Oncology Biosimilars Market Report encompasses the key factors driving the growth of the market, opportunities in the market and the factors posing threats & challenges to the market. The oncology biosimilars market outlook also comprises the market dynamics, risk analysis, SWOT analysis, USP analysis, BPS Analysis & market attractiveness. Report further also includes the expert analysis and remarks showcasing the complete overview of the market based on intensive analysis of political, economic, social, technological, environmental & legal factors of each region in the market.
Global Oncology Biosimilars Market is driving on the basis of advancement in branches of healthcare mentioned below:
Biopharmaceuticals Market
Biopharmaceuticals & biomedicine deals with the research and development of drugs (biologics) partially or completely using biological compounds. The year 2017 has witnessed huge growth in the Biopharmaceutical Market Biomedicines are increasingly penetrating the market as the drug manufacturers and other pharmaceutical companies are inclining towards R&D of biomedicine. 
Nano Chemotherapy Market
According to Goldstein Research, Nano chemotherapy market is expected to reach USD 3.5 billion by 2024, growing at a CAGR of 7.45% over the forecast period 2016-2024. The fact that the presence of bioavailability-improved Nanoscale particles and molecules in order to make drug delivery focuses on maximizing bioavailability both at specific places in the body and over a period of time is driving the growth of the Nano chemotherapy Industry
Chemotherapy Market
The global Chemotherapy Market is expected to reach a market size of USD 128.7 billion by 2025, growing at 63.0% CAGR over the forecast period 2017-2025. Chemotherapy is a cancer-curing treatment which is delivered either through site-specific or through the bloodstream. With the technological advancement and continuous R&D new cancer treatment drugs, devices and procedures are entering the Chemotherapy market.
Melanoma Scanner Market 
The Melanoma Scanner Market size is set to reach USD 850 million by 2025, at a CAGR of 7.6% over the forecast period. High investment by skin cancer diagnostic & therapeutic companies and an increasing number of pipeline products for cancer diagnosis under clinical trials are the key factors which are driving the growth of the market of melanoma scanners. Handheld melanoma scanner dominated the APAC Melanoma Scanner Market and accounted for the market share of 63.1% in 2017 of total melanoma scanner market attributed to the hand-held device are easy to learn and use, and it rapidly provides accurate images of the melanin, blood, and collagen below the mole or lesion.  The Handheld Melanoma Scanner Market size is set to reach USD 650 million by 2025, at a CAGR of 8.12% over the forecast years.

Cancer Services Market
The global cancer services market is projected to grow at a CAGR of 15.7% whereas global cancer therapy market is anticipated to grow at CAGR of 16.7% during the forecast period. Asia-Pacific cancer services market valued USD 15.3 billion in 2016. As per WHO, LA and MEA together accounted for 11.2% of total deaths caused by cancer.

 Contact for more Info:
Steve Blade                     
(Global Sales Head)
USA: + 1-646-568-7747
Canada:  +1-437-886-1181
UK: +44-203-318-6627
sales@goldsteinresearch.com
www.goldsteinresearch.com



Comments

Post a Comment

Popular posts from this blog

Global Behavioral/Mental Health Software Market Projected to Grow at a Robust CAGR of 13.49% over the Forecast Period 2016-2024

With high incidences in adoption of e-mental health services has led to be major driving factor for the growth of global behavioural/mental health software market . According to Goldstein Research, global behavioral/mental health software market size is expected to reach USD 2.35 billion by 2024, growing at a compounded annual growth rate of 13.49% during the forecast period 2016-2024. Global behavioral/mental health software market segmentation has been carried out on the basis of delivery mode, functionality, end user and geography. Based on delivery mode, subscription segment accounted for 74.25% behavioural/mental health software market share , owing to increasing acceptance of electronic health record systems. Further, Global behavioral/mental health software industry is estimated to be dominated by North America with a market share of 47.2% in 2016. Whereas, Asia Pacific is anticipated to be the opportunistic market, growing at a CAGR of 13.98% during the forecast period. ...
Post a Comment
Read more

Global Dead Sea Mud Cosmetic Market Outlook: Trends, Demand Analysis, Size, Share, & Forecast

According to Goldstein Research, intensifying inclination of consumers towards natural ingredients and organic products is the major factor motivating the demand for dead sea cosmetics. Moreover, limited availability can be attributed to the very small number of players in the Dead Sea mud cosmetics market. The market can be said to be oligopolistic in nature, with only a handful of players. Global dead sea mud cosmetic market outlook also includes product development, marketing and investment strategies adopted by major market players in order to expand their business across the globe. However, depletion of the Dead Sea and rising ecological concerns around it can potentially pose challenges for the Dead Sea mud cosmetics market over the forecast period. Market Segmentation On the basis of our in-depth analysis, global dead sea mud cosmetic market can be segmented as follows: By Product Type Facial Care ProductsFace WashesFace MoisturizersFace Serums Body Care ProductsBod...
Post a Comment
Read more

Philippines Hybrid Seeds Market Outlook 2017-2025

The developing agricultural sector of Philippines has huge potential to explore with the application of hybrid seeds. Hybrid seeds are produced by cross-pollination of plants method, done in home gardening and for commercial modern agriculture. Philippines agricultural sector accounted for 9% export of the total exports in 2016 and the agricultural industry has 10% contribution in GDP. In 2017, Philippines recorded the growth of 2.66% in crops sector, mainly from coconut, sugarcane, banana, pineapple, peanut, cassava, sweet potato, eggplant and rubber production.  The growth of agricultural sector is driving the growing demand for hybrid seeds, which is further impacted by the various hybrid seeds research and development programs and projects. One such example is the in the province of Nueva Ecija, where lies the Science City of Muñoz, to carry out agricultural research and innovations. Further, DuPont Pioneer has established its feet in the production of hybrid seeds, whi...
Post a Comment
Read more